Aeterna Zentaris Announces Results of Annual Meeting of Shareholders

Provided By Globe Newswire

Last update: Jun 21, 2022

- Vote to approve share consolidation adjourned to July 6, 2022

TORONTO, ONTARIO, June 21, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products, today announced that all items of business, other than the proposed consolidation of the Company's shares (the "Share Consolidation"), were approved at its annual meeting of shareholders (the "Meeting") held today.